Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Politics

WATCH: Parody drug ad spotlights RFK’s crackdown on misleading pharmaceutical marketing

by admin September 19, 2025
September 19, 2025
WATCH: Parody drug ad spotlights RFK’s crackdown on misleading pharmaceutical marketing

Shortly after announcing a strategy to go after deceptive direct-to-consumer advertising by the pharmaceutical industry, Robert F. Kennedy Jr. and the Department of Health and Human Services released a parody video of a drug advertisement – a pointed way of emphasizing the fact that the United States is largely unique in allowing drug ads.

‘Tired of endless drug ads promising quick fixes but leaving you sicker than you were before? That can change today. Ask your doctor about MAHA,’ the parody commercial begins, referring to Kennedy’s ‘Make America Healthy Again’ initiative. 

‘MAHA may cause healthier living, fewer chronic diseases, and lower drug costs,’ the video’s narrator continues. ‘Some Americans reported more time spent with family instead of at the pharmacy. Other side effects may include healthier children, a stronger nation, more transparency in healthcare, honest advertising, and accountability from Big Pharma.’

The drug advertisement parody comes after Kennedy and HHS laid out their plans to target direct-to-consumer drug advertising – something that isn’t widely allowed outside the United States – in a new children’s health strategy released earlier this month. 

The strategy said it will ramp up enforcement of current prescription drug advertising laws, with a priority on ‘egregious violations demonstrating harm from current practices.’ The strategy noted these violations could include the dissemination of ‘risk information and quality of life through misleading and deceptive advertising on social media and digital platforms.’

The strategy to go after direct-to-consumer drug ads will also include inter-agency cooperation to explore the development of potential new industry guidelines that limit direct-to-consumer advertising for certain ‘unhealthy foods’ to children. These efforts include ‘evaluating the use of misleading claims and imagery,’ the MAHA children’s strategy stated. 

Kennedy said alongside the release of HHS’s parody advertisement that the Trump administration plans to begin holding the pharmaceutical industry accountable for not sharing full safety information in their drug ads on television, radio and beyond.

 

‘No more hiding vital information in small print, or pushing it off to a website, or a 1-800 number,’ Kennedy said in a video released in conjunction with the parody advertisement. He also noted that regulators have been letting pharmaceutical manufacturers avoid providing complete warnings in their marketing materials.

Kennedy said in the accompanying video that, in the past, regulators let companies mention a vague ‘major statement’ of risk that required consumers to go elsewhere for important details about the drug. The secretary said this ‘loophole’ opened the door to a ‘tsunami’ of misleading advertisements.

‘Drug ads drove up prescription drug costs and distorted doctor-patient conversations. Patients saw glossy ads and often asked for new medications,’ Kennedy continued. ‘Big Pharma’s marketing hooked the country on prescription drugs. We’re taking action to end that practice.’

This post appeared first on FOX NEWS

previous post
Senate confirms dozens of Trump nominees in first test of new nuclear rules
next post
DC watchdog sues for docs on ‘modern-day Tuskegee Experiments’ giving transgender Rx to youth

Related Posts

New Russiagate evidence ‘directly’ points to Obama, DOJ...

July 24, 2025

Trump announces new ‘serious power’ fighter jets for...

April 30, 2025

Pentagon calls Charlie Kirk posts ‘domestic terrorism’; Dem...

September 16, 2025

The history of how Trump and Bolton’s relationship...

August 24, 2025

Starmer says UK to recognize Palestinian state if...

July 30, 2025

Epstein files debacle spurs new interest in contents...

March 1, 2025

China ramps up military ‘rehearsals’ around Taiwan, outstrips...

April 11, 2025

Trump praised for getting NATO allies to bolster...

March 14, 2025

How AI browsers open the door to new...

September 21, 2025

Emmanuel Macron calls ’emergency meeting’ for European leaders...

February 16, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 5

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved